Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transport of Satiety Hormones into the CNS
NCT04038086Unknown
- Sponsor
- University Hospital Tübingen
- Start
- Jul 2019
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Generex Oral-lyn in obesity (3 arms), sponsored by University Hospital Tübingen. Primary endpoint: Insulin transport into the CSF. Status: unknown.
02
Drugs
Generex Oral-lyn
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04038086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04038086.